PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
24261683-9	2014	Molecular docking results indicate the mutation in class A beta-lactamases which decrease the binding affinity of Cefpirome and Ceftobiprole which are third and fifth generation Cephalosporins, respectively.	Cephalosporins	178-192	amyloid beta precursor protein	Homo sapiens	57-63	
11001127-7	2000	A number of antibiotics, particularly the cephalosporins, have been demonstrated to be superior to penicillin at eradicating group A beta-hemolytic Streptococcus, and several are effective when administered for 4 to 5 days.	Cephalosporins	42-56	amyloid beta precursor protein	Homo sapiens	131-137	
20041005-1	2009	Efficacy of short-course therapy with cephalosporins for treatment of group A beta-hemolytic streptococcus (GABHS) pharyngitis is still controversial.	Cephalosporins	38-52	amyloid beta precursor protein	Homo sapiens	76-82	
25008823-1	2014	CONTEXT: The management of Group A beta-haemolytic Streptococci (Streptococcus pyogenes or GAS) infection include the use of penicillins, cephalosporins or macrolides for treatment.	Cephalosporins	138-152	amyloid beta precursor protein	Homo sapiens	33-39	
19285734-1	2009	BACKGROUND: Cephalosporins were found to be more effective than penicillins in the eradication of group A beta-hemolytic streptococcal (GABHS) from tonsillar tissues.	Cephalosporins	12-26	amyloid beta precursor protein	Homo sapiens	104-110	
34223109-2	2021	ESBL testing is an outdated practice established in an era of higher cephalosporin breakpoints to prevent resistant Enterobacterales carrying Ambler class A beta-lactamases with affinity for later-generation beta-lactams from being reported as susceptible to later-generation cephalosporins, leading to clinical failures.	Cephalosporins	69-82	amyloid beta precursor protein	Homo sapiens	155-161	
34223109-2	2021	ESBL testing is an outdated practice established in an era of higher cephalosporin breakpoints to prevent resistant Enterobacterales carrying Ambler class A beta-lactamases with affinity for later-generation beta-lactams from being reported as susceptible to later-generation cephalosporins, leading to clinical failures.	Cephalosporins	276-290	amyloid beta precursor protein	Homo sapiens	155-161	
6286266-8	1982	Minocycline and especially cefoxitin, a beta-lactamase resistant cephalosporin, inhibit with few exceptions all bacteria which are potentially involved in actinomykotic processes.	Cephalosporins	65-78	amyloid beta precursor protein	Homo sapiens	38-44	
3906584-0	1985	Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.	Cephalosporins	53-66	amyloid beta precursor protein	Homo sapiens	13-19	
6269426-0	1981	Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.	Cephalosporins	43-56	amyloid beta precursor protein	Homo sapiens	19-25